TEAM

​Harvard Medical School, Bayer, Novartis, Celgene, CMO of Ipsen​

• Chief Medical Officer, SVP and Head of Global Medical Affairs at Ipsen

• Vice President and Head of Global Medical Affairs Oncology for Baxalta Inc and Shire & roles in medical affairs and clinical development at Bayer Pharmaceuticals, Novartis Pharmaceuticals and Celgene Corporation 

• Trained in Internal Medicine and Cancer Genetics from NIH, Albert Einstein College of Medicine and Harvard Medical School

• Masters of Biotechnology Enerprise and Entrepreneurship from Johns Hopkins University

Research and Biotech focused capital markets with Goldman Sachs, Credit Suisse & UBS​​

• MBA from University of Illinois at Urbana-Champaign

• Former VP at UBS, Oppenheimer & Co., Credit Suisse, and Kidder Peabody

• Former analyst at Goldman Sachs and Salomon Brothers

• 30 years of experience in finance

• Has worked extensively with biotech companies in financing and investment decisions

Harvard University Postdoc Leukemia Research, BD Ironwood and Rafael Pharma​

• PhD in Human Biology from Ludwig-Maximilians University

• MBA from Boston University

• Postdoctoral research at Harvard University in leukemia and the target of AO-001

• Authored several articles in oncology in leading publications

• Biotechnology industry analyst experience at Jeffries LLC 

Medicinal and Computational Chemist. Seoul National University, University of Pittsburgh, UPCDC ​

• PhD in Synthetic and Medicinal Chemistry from the Seoul National University

• Postdoctoral research in Chemistry from the University of Pittsburgh

• Extensive research experience in synthetic organic chemistry and drug discovery covering multiple therapeutic areas

• Co-authored 20 SCI papers and 9 patent applications as a co-inventor

• Has contributed to drug discovery and development projects ranging from early development stages through to preclinical trials particularly using in silico drug design tools

Machine Learning and Computational Chemist 

• Master in Computer Science, Cornell Tech

• Chemist, Univ. South Florida

• Bryd Alzheimers Institute, Center of Disease and Drug Innovation Medicinal Chemist

• Development of Novel Therapeutics using Cannabinoid analogs for Alzheimer's and Other Neurodegenerative Diseases.